The molecular pathogenesis of breast fibroepithelial tumors continues to be elucidated. Recently, highly recurrent MED12 mutations arising in exon 2 at codon 44 were discovered in fibroadenomas and phyllodes tumors. In addition, a high prevalence of TERT promoter mutations in two hotspots (124 and 126 bp upstream from the translation start site) was discovered in up to 65% of phyllodes tumors. Breast periductal stromal tumors are a potentially distinct category of fibroepithelial lesions that are exceptionally rare with controversial classification and pathogenesis. Herein, we report the first comprehensive molecular genetic workup of a breast periductal stromal tumor that harbored a TERT promoter −124C > T mutation, supporting a relation to phyllodes tumors.
BurgaAMTavassoliFA. Periductal stromal tumor: a rare lesion with low-grade sarcomatous behavior. Am J Surg Pathol. 2003;27:343‐348.
2.
WHO Classification of Tumours Editorial Board. Breast Tumours. Vol 2. 5th ed.; 2019.
3.
LimWKOngCKTanJ, et al.Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma. Nat Genet. 2014;46:877‐880.
4.
PfarrNKriegsmannMSinnP, et al.Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast—implications for tumor biology and pathological diagnosis. Genes Chromosomes Cancer. 2015;54:444‐452.
5.
PiscuoglioSMurrayMFuscoN, et al.MED12 Somatic mutations in fibroadenomas and phyllodes tumours of the breast. Histopathology. 2015;67:719‐729.
6.
TanJOngCKLimWK, et al.Genomic landscapes of breast fibroepithelial tumors. Nat Genet. 2015;47:1341‐1345.
7.
LienHCHuangCSYangYW, et al.Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: implications for pathogenesis and histogenesis. Histopathology. 2016;68:433‐441.
8.
ParejaFDa Cruz PaulaAMurrayM, et al.Recurrent MED12 exon 2 mutations in benign breast fibroepithelial lesions in adolescents and young adults. J Clin Pathol. 2019;72:258‐262.
9.
YoshidaMOgawaRYoshidaH, et al.TERT Promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast. Br J Cancer. 2015 Oct 20;113:1244‐1248.
10.
PiscuoglioSNgCKYMurrayM, et al.Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression. J Pathol. 2016 Mar;238:508‐518.
11.
ParejaFGeyerFCKumarR, et al.Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways. NPJ Breast Cancer. 2017;3:40.
12.
Garcia-DiosDALeviDShahV, et al.MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours. Br J Cancer. 2018;118:277‐284.
13.
ChangHYKohVCYMd NasirND, et al.MED12, TERT and RARA in fibroepithelial tumours of the breast. J Clin Pathol. 2020;73:51‐56.
14.
HolzmannCHelmkeBBullerdiekJ. Gross genetic alterations and genetic heterogeneity in a periductal stromal tumor of the breast. Mol Cytogenet. 2020;13:49.
15.
TanBYAcsGAppleSK, et al.Phyllodes tumours of the breast: a consensus review. Histopathology. 2016;68:5‐21.
16.
ZhaoLKomfortiMKDawsonA, et al.Periductal stromal tumor of the breast: one institution’s review of 6 tumors over a 22 year period with immunohistochemical analysis. Int J Surg Pathol. 2022;30:370‐377.
17.
TsangJYSHuiY-KLeeMA, et al.Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast. Sci Rep. 2018;8:3881.
18.
NgCCYMd NasirNDLokeBN, et al.Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing. Mod Pathol. 2021;34:1320‐1332.
19.
LvSNiuYWeiL, et al.Chromosomal aberrations and genetic relations in benign, borderline and malignant phyllodes tumors of the breast: a comparative genomic hybridization study. Breast Cancer Res Treat. 2008;112:411‐418.
20.
AmielAKaufmanZGoldsteinE, et al.Application of comparative genomic hybridization in search for genetic aberrations in fibroadenomas of the breast. Cancer Genet Cytogenet. 2003;142:145‐148.
21.
CavalliLRCornelioDALimaRS, et al.Lack of DNA copy number alterations revealed with comparative genomic hybridization in fibroadenomas of the breast. Cancer Genet Cytogenet. 2004;153:173‐176.
